Le Lézard11h
OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing
OS Therapies, Inc. , a clinical-stage biotechnology company advancing immunotherapies and targeted drug conjugates for cancer treatment, today announced that it has entered into agreements for the ...
Origin Agritech Limited (NASDAQ:SEED) Q4 2024 Earnings Call Transcript
Operator: Thank you for standing by, and welcome to the Origin Agritech Fiscal Year 2024 Conference Call. Please note that, today ...
China to develop gene-editing tools, new crop varieties in biotech initiative
China issued guidelines on Friday to promote biotech cultivation, focusing on gene-editing tools and developing new wheat, ...
China's agriculture ministry issues guidelines to promote biotech cultivation
China's agriculture ministry issued guidelines on Friday to promote biotech cultivation from 2024 to 2028, a ministry statement showed. The focus will be on developing precision gene-editing tools ...